Optimizing Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma: A Risk‐Stratified Recursive Partitioning Analysis Based on 9th Edition Staging
International Journal of Cancer · 16.11.2026
DOI: 10.1002/ijc.70819 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 16.11.2026. Verfasst von Jieyi Lin und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Department of Nasopharyn…. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China, The Research Foundation of Medical Science and Technology of Guangdong Province.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Although induction chemotherapy (IC) in combination with concurrent chemoradiotherapy constitutes the standard treatment for locally advanced nasopharyngeal carcinoma (LANPC), the optimal number of IC cycles remains undetermined. The 9th edition staging system provides a refined risk stratification framework. We aimed to develop a prognostic tool to stratify patients with LANPC and define the optimal number of IC cycles for distinct risk groups based on new staging. We analyzed 1216 patients with LANPC treated with IC and employed propensity score matching to minimize bias. Progression‐free survival (PFS) was the primary endpoint, analyzed using Kaplan–Meier curves. A recursive partitioning analysis (RPA) model was developed and validated for risk stratification. Survival outcomes and toxicities were compared across IC cycle groups. After a median follow‐up of 56 months, 2‐ and 3‐cycle IC yielded greater improvements in PFS compared with 4‐cycle IC ( p < 0.001). The RPA model incorporated 9th edition staging, pretreatment EBV DNA, and IC response, stratifying patients into three risk categories. For low‐risk patients, 2‐ and 3‐cycle IC yielded comparable PFS, both superior to 4‐cycle IC ( p < 0.001). In intermediate‐risk patients, significantly higher 5‐year PFS was achieved with 2‐cycle IC than with 3‐ (73.4% vs. 56.2%, p = 0.014) or 4‐cycle IC (73.4% vs. 47.5%, p < 0.001). High‐risk patients benefited more from 3‐cycle versus 2‐ (47.5% vs. 31.7%; p = 0.038) or 4‐cycle IC (47.5% vs. 36.2%; p = 0.039). Overall, the RPA‐based model effectively stratified risk, guiding individualized IC cycle selection. Balancing toxicity and efficacy, 2‐cycle IC is optimal for the low‐ and intermediate‐risk groups, while 3‐cycle IC is preferred for the high‐risk group.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Department of Nasopharyngeal Carcinoma, Collaborative Innovation Center for Cancer Medicine, S…
- Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China.
- Breast Disease Center, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China.
ORCID-Profile: Haoyuan Mo, Ruiling Xie, Haiqiang Mai, Qiuyan Chen
Förderung
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- National Natural Science Foundation of China
- The Research Foundation of Medical Science and Technology of Guangdong Province
- China Postdoctoral Science Foundation
Zitieren
APA
Lin, J., Wang, T., Xiao, J., Lin, J., Liu, T., Lu, J., Mo, H., Xie, R., Mai, H., & Chen, Q. (2026). Optimizing Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma: A Risk‐Stratified Recursive Partitioning Analysis Based on 9th Edition Staging. International Journal of Cancer. https://doi.org/10.1002/ijc.70819
Vancouver
Lin J, Wang T, Xiao J, Lin J, Liu T, Lu J, et al. Optimizing Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma: A Risk‐Stratified Recursive Partitioning Analysis Based on 9th Edition Staging. International Journal of Cancer. 2026. doi:10.1002/ijc.70819
BibTeX
@article{Lin2026,
author = {Lin, Jieyi and Wang, Tianyi and Xiao, Jiashi and Lin, Jiaying and Liu, Ting and Lu, Jinjing and Mo, Haoyuan and Xie, Ruiling and Mai, Haiqiang and Chen, Qiuyan},
title = {Optimizing Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma: A Risk‐Stratified Recursive Partitioning Analysis Based on 9th Edition Staging},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70819}
}
EUVIMED